| Queen Downing, | |
|
524 Woodstone Rd, Lithonia, GA 30058-5900 | |
| (404) 840-9015 | |
| Not Available |
| Full Name | Queen Downing |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse |
| Location | 524 Woodstone Rd, Lithonia, Georgia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124477567 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | RN065182 (Georgia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Queen Downing, 524 Woodstone Rd, Lithonia, GA 30058-5900 Ph: (404) 840-9015 | Queen Downing, 524 Woodstone Rd, Lithonia, GA 30058-5900 Ph: (404) 840-9015 |
News Archive
New research from the University of Minnesota College of Veterinary Medicine has uncovered the role gene ORMDL3 plays in the disease asthma. ORMDL3, a gene recently linked to asthma susceptibility, has now been linked to the body's ability to recruit inflammatory cells during an airway allergic reaction. Study findings appear today in the journal Nature Communications.
The science team from Advaxis, Inc., the live, attenuated Listeria monocytogenes (Listeria) immunotherapy company, met with the Data Safety Monitoring Board (DSMB), an independent group of medical experts, yesterday and received approval to dose all remaining patients in the initial forty (40) patient leg of the 120-patient, cervical dysplasia clinical trial being conducted in the United States.
Social scientists at the University of York are to investigate public attitudes to the way medical information relating to hundreds of thousands of people is managed, particularly the rules governing third-party access to the data.
Vaxonco Inc., a Korean company specializing in peptide-based vaccines and Ichor Medical Systems (Ichor), whose advanced TriGrid™ Delivery System (TriGrid™) is being tested worldwide for its ability to enhance delivery of DNA drugs and vaccines, announced today the initiation of a Phase I clinical trial to evaluate a novel DNA-based polyepitope vaccine against malaria.
BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) announced today that the first patient has initiated treatment in the Phase 2 clinical study of PEG-PAL (PEGylated recombinant phenylalanine ammonia lyase) for the treatment of phenylketonuria (PKU). Initial top-line results are expected in mid-2010.
› Verified 2 days ago
Rodney Daye, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 6302 Fairington Village Dr, Lithonia, GA 30038 Phone: 404-759-6885 | |
Christine M. Palomino, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 2277 Stone Mountain Lithonia Rd, Lithonia, GA 30058 Phone: 770-484-2600 Fax: 770-484-0155 | |
Mrs. Janice Teresa Jemison, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1426 Greenridge Trl, Lithonia, GA 30058 Phone: 404-556-7357 | |
Theresa Hannah Walcot-ceesay, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 5734 Winchester Pl, Lithonia, GA 30038 Phone: 404-859-3216 | |
Mrs. Jerolynn J Hood, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 4915 Thompson Mill Rd, Lithonia, GA 30038 Phone: 678-467-7340 | |
Lisa J Wolfgang, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 2277 Stone Mountain Lithonia Rd, Lithonia, GA 30058 Phone: 770-484-2600 Fax: 770-484-0155 |